| pubmed-article:6328769 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6328769 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:6328769 | lifeskim:mentions | umls-concept:C0021745 | lld:lifeskim |
| pubmed-article:6328769 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:6328769 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:6328769 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6328769 | pubmed:dateCreated | 1984-7-19 | lld:pubmed |
| pubmed-article:6328769 | pubmed:abstractText | The most marked production of immune interferon by human peripheral blood leukocytes and splenocytes stimulated with phytohemagglutinin (PHA) and staphylococcal enterotoxin A (SEA) was shown to be achieved when lymphoid cells are propagated under conditions of constant sparing mixing on roller apparatus at a temperature of 37 degrees +/- 0.5 degrees C. The resulting interferon was sensitive to low pH, thermolabile, inactivated by treatment with trypsin, and not neutralised by antisera to human alpha- and beta-interferons. The antiviral properties with regard to vesicular stomatitis and Semliki Forest viruses were practically similar in PHA- and SEA-induced interferon and human alpha- and beta-interferons. The capacity to inhibit colony formation by HeLa cells was 30 times higher in gamma-interferon than the antiproliferative activity of alpha- and beta-interferons. | lld:pubmed |
| pubmed-article:6328769 | pubmed:language | rus | lld:pubmed |
| pubmed-article:6328769 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6328769 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6328769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6328769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6328769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6328769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6328769 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6328769 | pubmed:issn | 0507-4088 | lld:pubmed |
| pubmed-article:6328769 | pubmed:author | pubmed-author:Novokhatski?A... | lld:pubmed |
| pubmed-article:6328769 | pubmed:author | pubmed-author:AspetovR DRD | lld:pubmed |
| pubmed-article:6328769 | pubmed:author | pubmed-author:ShuratovI... | lld:pubmed |
| pubmed-article:6328769 | pubmed:author | pubmed-author:Burshte?nE... | lld:pubmed |
| pubmed-article:6328769 | pubmed:author | pubmed-author:NosikD NDN | lld:pubmed |
| pubmed-article:6328769 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6328769 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:6328769 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6328769 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6328769 | pubmed:pagination | 240-5 | lld:pubmed |
| pubmed-article:6328769 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:meshHeading | pubmed-meshheading:6328769-... | lld:pubmed |
| pubmed-article:6328769 | pubmed:articleTitle | [Human immune interferon: production and action]. | lld:pubmed |
| pubmed-article:6328769 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6328769 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:6328769 | pubmed:publicationType | English Abstract | lld:pubmed |
